Healthcare stocks in Switzerland

Intrinsic value and value investing analysis for healthcare stocks in Switzerland.

13 companies

Companies

• NVS - Novartis AG ADR: slightly overvalued, -18% margin of safety
• ONC - BeOne Medicines Ltd ADR: overvalued, -202% margin of safety
• ALC - Alcon Inc: overvalued, -177% margin of safety
• CRSP - CRISPR Therapeutics AG: overvalued, -203% margin of safety
• MLTX - MoonLake Immunotherapeutics: no published value
• SOPH - SOPHiA Genetics SA: overvalued, -569% margin of safety
• OCS - Oculis Holding AG: no published value
• ACIU - AC Immune SA: not valued
• ADCT - Adc Therapeutics SA: slightly overvalued, -5% margin of safety
• VRXA - Veraxa Biotech AG: no published value
• MOLN - Molecular Partners AG ADR: no published value
• NCEL - NewcelX Ltd: no published value
• ADXN - Addex Therapeutics Ltd ADR: overvalued, -3047% margin of safety